The CEO of French consumer goods giant Danone on Wednesday downplayed the threat of obesity drugs on its food business. Antoine de Saint-Affrique told CNBC that surging demand for drugs like Wegovy ...

Gift Article 10 Remaining As a subscriber, you have 10 articles to gift each month. Gifting allows recipients to access the article for free. Stymied in its takeover bid for Lifeway Foods, minority ...

Reflecting its earnings and cash-flow progress, Danone’s board will propose a dividend of EUR 2.25 per share, an increase of about 5% year-on-year. The payout rise roughly tracks EPS growth, ...

The health firm backed by actor Idris Elba and broadcaster Jonathan Ross is being bought by Danone, reportedly for €1bn (£860m).

Danone and Nutri-Score’s relationship wasn’t always sour. When the nutrition labelling scheme first entered the market, Danone was among the first adopters. Soon, Danone was rallying for the mandatory ...

Divestitures in Q1-2024 indicate that management continues to execute its “Renew Danone” plan, with a primary focus still on internal reorganization. Net income has been battered by extraordinary ...